Showing results (861-870 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|February 2, 2025
Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trialsCecilia Nasso, Silvia Puglisi, Sara Elena Rebuzzi, et al.Immunotherapy|December 19, 2023
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case reportLing-Zhijie Kong, Ying Zheng, Kaichun LiImmunotherapy|December 21, 2023
Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapyXiaoli Liu, Shuochuan Liu, Zhiqiang Jiang, et al.Immunotherapy|December 21, 2023
Immunotherapy for head and neck squamous cell carcinoma: current status and perspectivesAmaury Daste, Mathieu Larroquette, Nyere Gibson, et al.Immunotherapy|November 30, 2023
A plain language summary describing how two different concentrations of GP2017, a biosimilar adalimumab medicine, are associated with similar drug levels within the bodySilvio Danese, Piotr Wiland, Russell Cohen, et al.Immunotherapy|November 29, 2023
Role of ustekinumab in treatment of ulcerative colitis: a narrative reviewMauro Grova, Alessandro Vitello, Mariella Mannino, et al.Immunotherapy|November 29, 2023
Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance studyFranco Frati, Noemi De Beni, Laura Marastoni, et al.Immunotherapy|January 24, 2024
BATF-mediated regulation of exhausted CD8+ T-cell responses and potential implications for chimeric antigen receptor-T therapyChao Sun, Dan Li, Zhengxin WangImmunotherapy|January 10, 2024
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancerRamon Andrade de Mello, Kátia Roque Perez, Thais Pérez VazquezImmunotherapy|January 12, 2024
Effect of sublingual immunotherapy on clinical and laboratory autoimmunityAndrzej Bozek, Szymon Mućka, Martyna Miodonska, et al.Pageof 190